GlycoMimetics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-36.9	-46.69	-63.43	-51.03	-57.89	-48.27	-33.28	-31.81	-12.77	-11.12	Upgrade
Depreciation & Amortization	1.01	1.03	1.01	0.95	0.9	0.28	0.26	0.19	0.19	0.16	Upgrade
Share-Based Compensation	3.56	3.86	6.09	6.9	6.22	4.59	3.76	2.96	2.32	1.64	Upgrade
Other Operating Activities	-2.55	-4.66	-1.16	3.93	-1.21	0.08	-0.51	-1.08	2.01	5.05	Upgrade
Operating Cash Flow	-34.88	-46.46	-57.49	-39.24	-51.98	-43.33	-29.77	-29.73	-8.24	-4.28	Upgrade
Capital Expenditures	-0.02	-0.08	-0.01	-0.07	-0.14	-0.13	-0.29	-0.7	-0.27	-0.21	Upgrade
Investing Cash Flow	-0.02	-0.08	-0.01	-0.07	-0.14	-0.13	-0.29	-0.7	-0.27	-0.21	Upgrade
Share Issuance / Repurchase	28.82	4.16	10.72	18.14	0.41	129.45	113.95	23.67	0.11	57.38	Upgrade
Financing Cash Flow	28.82	4.16	10.72	18.14	0.41	129.45	113.95	23.67	0.11	57.38	Upgrade
Net Cash Flow	-6.08	-42.38	-46.78	-21.17	-51.72	85.99	83.88	-6.76	-8.4	52.89	Upgrade
Free Cash Flow	-34.9	-46.54	-57.5	-39.31	-52.13	-43.46	-30.06	-30.44	-8.51	-4.49	Upgrade
Free Cash Flow Margin	-349012.97%	-62055.57%	-4958.28%	-386.80%	-	-	-	-164516.04%	-42.40%	-29.91%	Upgrade
Free Cash Flow Per Share	-0.55	-0.89	-1.12	-0.86	-1.21	-1.06	-1.02	-1.43	-0.45	-0.24	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).